Botanix Pharmaceuticals Limited announced the appointment of Dr. Michael Thurn, Head of Australian Operations, as Executive Director. Dr. Thurn has over two decades of experience in the life sciences and biotechnology industry and has accumulated extensive knowledge in drug regulation, drug discovery, pre-clinical and clinical development across dermatology in Australia and the United States.